Dietary interventions can improve clinical outcomes for some women with breast cancer
the ONA take:
Data from the Women’s Intervention Nutrition Study (WINS) presented at the San Antonio Breast Cancer Symposium demonstrated that reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
The WINS was a randomized trial, to which 2,437 women ages 48 to 79 years were recruited. The women had early stage hormone-unrelated breast cancer, receiving standard-of-care treatments at 39 centers in the United States. They were randomly assigned to follow a dietary intervention that reduced their fat intake for 5 years following diagnosis (975 patients) or to a control group (1,462 patients).
Centrally trained, registered dietitians implemented the low-fat eating plan via eight biweekly individual counseling sessions and subsequent contacts every 3 weeks, plus unannounced 24-hour telephone recalls performed annually. In addition, the women self-monitored and recorded their fat intake in a book. After more than 15 years of follow-up, death rates from all causes in the intervention group were significantly lower than in the control group.
“The dietary intervention was supported for a median of 5 years,” the researchers reported. Based on their findings, however, the researchers suggest that for lifestyle interventions to have a long-term influence on clinical outcomes, they must be lifelong changes rather than short-term interventions.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|